is glp 1 patches fda approved GLP-1 Patch for Weight Loss glp-1 patch clinical trial Do

Tesamorelin (trade name Egrifta, Theratechnologies) received FDA approval in November 2010 for the reduction of excess abdominal fat (lipodystrophy) in HIV patients undergoing antiretroviral therapy

One injection per week, with gradual dose escalation to maximize results and minimize early side effects

Second, the study was limited by the small sample size and the short treatment period (4 months)

Many patients later restarted the original medication or switched to an alternative obesity treatment

It also shares the same product page as the 500mg version, so double-check that youre getting the product you want

[46:04] A Oh, wait, no, I